Novavax: The Short Squeeze Story Isn’t A Complete No-Brainer (NASDAQ:NVAX)

Herstellung von Covid-19 Vaccine Vials In Cold Storage

solarseven/iStock via Getty Images


Novavax, Inc. (NASDAQ:NVAX), a prominent biotech company, distinguished itself during the COVID-19 pandemic by pioneering a spike protein-based COVID-19 vaccine, deviating from the widely adopted mRNA technology used by its competitors. However, Novavax’s stock has recently

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *